Skip to main content
OpenTrials

Clinical trial condition

Small-cell Lung Cancer

Explore clinical trials studying Small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

75 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Small-cell Lung Cancer trial results

Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

NCT03219268

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +48 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 40 locations
View Trial Details
Completed

A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors

NCT04247126

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
View all 16 locations
View Trial Details
Completed

Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer

NCT03371979

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Colorado Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Mid Florida Hematology and Oncology Centers Orange City, Florida, United States
View all 22 locations
View Trial Details
Completed

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

NCT02566993

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • St Jude Hospital Yorba Linda dba St Joseph Heritage Healthcare Fullerton, California, United States
  • Loma Linda University Medica! Center Loma Linda, California, United States
View all 160 locations
View Trial Details
Completed

Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

NCT00466466

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC

NCT02058056

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Universitätsspital Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Kantonsspital Graubuenden Chur, Switzerland
View Trial Details

Related conditions